EBITDA of $1.3m was ahead of my estimates The amortisation of the capitalised GO development costs of $822k as expected impacts NPAT Looks like the business is progressing nicely
OCC Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil